Histologically, MPNST is characterized by hypercellular spindle cell proliferation with marked nuclear atypia, frequent necrosis, and endothelial proliferation
Secondary analyses of the MAESTRO-NASH trial suggest that resmetirom retains efficacy in patients concomitantly using GLP-1 RAs, supporting the feasibility of combination approaches [71]
The American Diabetes Association (ADA) Standards of Care and American College of Physicians (ACP) guidelines support the use of GLP-1 receptor agonists, including dual agonists like tirzepatide, as effective options for glycemic control and weight management
Over 100 preclinical studies document tissue repair, gastrointestinal protection, wound healing, and neuroprotective effects
over time, seasons of rain and years of drought
(Lond.) 458 , 261287 (1992) Hausser, M